You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys PRO-C3 IVD Elecsys® PRO-C3 PID00000984 09 088 423 190 9 088 423 190 09088423190 9088423190 09088423190 Pro-C3 Elecsys E2G 100 Elecsys PRO-C3 07613336197875 Reagents, kits 100 tests cobas e 402/801 true 09088423500 Elecsys PRO-C3 en 1 FF0000000756B10E FF0000000756B00E 09088423190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useElecsys PRO‑C3 is an in vitro quantitative immunoassay for the determination of N‑terminal pro‑peptide of type III collagen (PRO‑C3) in human serum and plasma.The assay is intended to be used as part of the ADAPT algorithm (patient age, diabetes status, PRO‑C3, platelet count) to assess the severity of hepatic fibrosis in patients showing evidence or signs of metabolic dysfunction-associated steatotic liver disease (MASLD). The ADAPT result must be interpreted in conjunction with other methods and in accordance with standard clinical management guidelines.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en